Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore

Urinary 6-Sulphatoxymelatonin Levels and Risk of Breast Cancer in Premenopausal Women: The ORDET Cohort

(2010) E. S. Schernhammer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Measuring Serum Melatonin in Epidemiologic Studies

(2010) A. W. Hsing et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses' Health Study Cohort

(2009) E. S. Schernhammer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Light-Mediated Perturbations of Circadian Timing and Cancer Risk: A Mechanistic Analysis

(2009) Russel J. Reiter et al.   INTEGRATIVE CANCER THERAPIES

Light Hygiene: Time to make preventive use of insights – old and new – into the nexus of the drug light, melatonin, clocks, chronodisruption and public health

(2009) Thomas C. Erren et al.   MEDICAL HYPOTHESES

Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study

(2008) M Kakizaki et al.   BRITISH JOURNAL OF CANCER

Sleep duration, melatonin and breast cancer among Chinese women in Singapore

(2008) A. H. Wu et al.   CARCINOGENESIS

Urinary 6-Sulfatoxymelatonin Levels and Risk of Breast Cancer in Postmenopausal Women

(2008) E. S. Schernhammer et al.   JNCI-Journal of the National Cancer Institute